ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 251 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,009,936 | -16.1% | 240,400 | -3.6% | 4.26% | -4.8% |
| Q2 2023 | $5,973,130 | +127150.3% | 249,400 | 0.0% | 4.48% | +21.8% |
| Q1 2023 | $4,694 | +18.2% | 249,400 | 0.0% | 3.68% | +31.1% |
| Q4 2022 | $3,970 | -99.9% | 249,400 | 0.0% | 2.80% | -2.4% |
| Q3 2022 | $4,080,000 | +16.1% | 249,400 | 0.0% | 2.87% | +12.4% |
| Q2 2022 | $3,514,000 | -27.2% | 249,400 | +25.1% | 2.56% | -26.5% |
| Q1 2022 | $4,829,000 | +3.8% | 199,400 | 0.0% | 3.48% | +15.9% |
| Q4 2021 | $4,654,000 | +40.5% | 199,400 | 0.0% | 3.00% | +33.1% |
| Q3 2021 | $3,312,000 | -31.9% | 199,400 | 0.0% | 2.25% | -22.5% |
| Q2 2021 | $4,863,000 | +6.5% | 199,400 | +12.7% | 2.91% | +7.3% |
| Q1 2021 | $4,567,000 | -16.2% | 177,000 | +73.5% | 2.71% | -13.7% |
| Q4 2020 | $5,453,000 | -35.2% | 102,000 | -50.0% | 3.14% | +11.8% |
| Q3 2020 | $8,416,000 | +86.7% | 204,000 | +119.4% | 2.81% | +3.2% |
| Q2 2020 | $4,508,000 | +16.0% | 93,000 | +1.1% | 2.72% | -21.0% |
| Q1 2020 | $3,887,000 | +548.9% | 92,000 | +557.1% | 3.45% | +692.6% |
| Q4 2019 | $599,000 | +18.8% | 14,000 | 0.0% | 0.44% | +29.5% |
| Q3 2019 | $504,000 | +88.8% | 14,000 | +40.0% | 0.34% | +107.4% |
| Q2 2019 | $267,000 | – | 10,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |